日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial

Selpercatinib治疗RET融合阳性非小细胞肺癌:LIBRETTO-001 I/II期试验的最终安全性和有效性,包括总生存期

Gautschi, Oliver; Park, Keunchil; Solomon, Benjamin J; Tomasini, Pascale; Loong, Herbert H; De Braud, Filippo; Goto, Koichi; Peterson, Patrick; Barker, Scott; Liming, Katherine; Oxnard, Geoffrey R; Frimodt-Moller, Bente; Drilon, Alexander

Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study

阿米万单抗联合化疗治疗EGFR 20号外显子插入突变的非小细胞肺癌:PAPILLON III期研究中治疗交叉及其他终点的影响

Sanborn, Rachel E; Zhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Cheng, Susanna; Popat, Sanjay; Ono, Akira; Lu, Shun; Majem, Margarita; Aguilar, Andres; Del Rosario Garcia Campelo, Maria; Hayashi, Hidetoshi; Lee, Kang-Yun; Lee, Se-Hoon; Delmonte, Angelo; Alatorre-Alexander, Jorge; Richardson, Gary; Santos, Victor; Dooms, Christophe; Sabari, Joshua K; Shu, Catherine A; Girard, Nicolas; Mansfield, Aaron S; Park, Keunchil; Xia, Yichuan; Bhattacharya, Archan; Buyukkaramikli, Nasuh; Perualila, Nolen; Diels, Joris; Acharya, Sandip; Chandler, Conor; Proskorovsky, Irina; Dearden, Lindsay; Wortman-Vayn, Honeylet; Mahadevia, Parthiv J; Knoblauch, Roland E; Agrawal, Trishala; Baig, Mahadi; Felip, Enriqueta

The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group

韩国癌症研究组开展的研究者发起试验的生存率和经济效益

Kim, Bum Jun; Maeng, Chi Hoon; Keam, Bhumsuk; Im, Young-Hyuck; Ro, Jungsil; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae Won; Lee, Jae Lyun; Heo, Dae Seog; Kim, Sang-We; Park, Keunchil; Ahn, Myung-Ju; Cho, Byoung Chul; Kim, Hoon-Kyo; Kang, Yoon-Koo; Cho, Jae Yong; Yun, Hwan Jung; Nam, Byung-Ho; Zang, Dae Young

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

生物标志物导向的靶向治疗联合度伐单抗治疗晚期非小细胞肺癌:一项 2 期伞状试验

Benjamin Besse, Elvire Pons-Tostivint, Keunchil Park, Sylvia Hartl, Patrick M Forde, Maximilian J Hochmair, Mark M Awad, Michael Thomas, Glenwood Goss, Paul Wheatley-Price, Frances A Shepherd, Marie Florescu, Parneet Cheema, Quincy S C Chu, Sang-We Kim, Daniel Morgensztern, Melissa L Johnson, Sophie

CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer

塞帕替尼对一线RET融合阳性晚期非小细胞肺癌的中枢神经系统保护作用

Pérol, Maurice; Solomon, Benjamin J; Goto, Koichi; Park, Keunchil; Nadal, Ernest; Bria, Emilio; Martin, Claudio; Bar, Jair; Williams, Justin N; Puri, Tarun; Li, Jian; Uh, Minji K; Lin, Boris K; Zhou, Caicun

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722

在表皮生长因子受体酪氨酸激酶抑制剂治疗后疾病进展的表皮生长因子受体突变转移性非小细胞肺癌中,纳武利尤单抗联合化疗:CheckMate 722 研究的最终结果

Mok, Tony; Nakagawa, Kazuhiko; Park, Keunchil; Ohe, Yuichiro; Girard, Nicolas; Kim, Hye Ryun; Wu, Yi-Long; Gainor, Justin; Lee, Se-Hoon; Chiu, Chao-Hua; Kim, Sang-We; Yang, Cheng-Ta; Wu, Chien Liang; Wu, Lin; Lin, Meng-Chih; Samol, Jens; Ichikado, Kazuya; Wang, Mengzhao; Zhang, Xiaoqing; Sylvester, Judi; Li, Sunney; Forslund, Ann; Yang, James Chih-Hsin

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

阿米万单抗治疗EGFR突变型非小细胞肺癌的真实世界疗效和安全性

Wang, Kaiwen; Du, Robyn; Myall, Nathaniel J; Lewis, Whitney E; Uy, Natalie; Hong, Lingzhi; Skoulidis, Ferdinandos; Byers, Lauren A; Tsao, Anne; Cascone, Tina; Pozadzides, Jenny; Tu, Janet; Negrao, Marcelo V; Gibbons, Don L; Park, Keunchil; Rinsurongkawong, Waree; Lee, J Jack; Gandara, David; Behl, Deepti; Shu, Catherine A; Riess, Jonathan W; Baik, Christina; Wakelee, Heather A; Vaporciyan, Ara A; Heymach, John V; Zhang, Jianjun; Le, Xiuning

Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer

综合分析小细胞肺癌转录因子的分子亚型及其与临床结果的相关性

Sehhoon Park, Tae Hee Hong, Soohyun Hwang, Simon Heeke, Carl M Gay, Jiyeon Kim, Hyun-Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Jong Ho Cho, Yong Soo Choi, Jhingook Kim, Young Mog Shim, Hong Kwan Kim, Lauren Averett Byers, John V Heymach, Yoon-La Choi, Se-Hoon Lee, Keunchil Park

Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non-Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial

新辅助同步放化疗后完全切除的IIIA/N2期非小细胞肺癌患者接受辅助帕博利珠单抗治疗:一项前瞻性、开放标签、单臂II期试验

Shin, Junghoon; Park, Sehhoon; Kim, Kyung Hwan; Shin, Eui-Cheol; Jung, Hyun Ae; Cho, Jong Ho; Sun, Jong-Mu; Lee, Se-Hoon; Choi, Yong Soo; Ahn, Jin Seok; Kim, Jhingook; Park, Keunchil; Shim, Young Mog; Kim, Hong Kwan; Noh, Jae Myoung; Ahn, Yong Chan; Pyo, Hongryull; Ahn, Myung-Ju

Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses

利用无细胞DNA突变和片段组分析预测局限期小细胞肺癌的疾病复发

Park, Sehhoon; Kang, Jun-Kyu; Lee, Naeun; Lee, Se-Hoon; Kim, Hwang-Phill; Kim, Su Yeon; Kim, Tae-You; Kim, Hyemin; Jung, Hyun Ae; Sun, Jong-Mu; Ahn, Jin Seok; Ahn, Myung-Ju; Park, Keunchil